For example, the screening for organic cation/carnitine transporter 2 (OCTN2) deficiency in newborns may detect carnitine deficiency in asymptomatic mothers, which is beyond the goal of NBS and may have a medical and/or psychological impact on these women [15]. This evidence concerns the gene SLC22A5 and systemic primary carnitine deficiency disease.